Rhian Gabe

Professor Rhian Gabe is a Professor of Biostatistics and Clinical Trials at Queen Mary University of London, affiliated with the Wolfson Institute of Population Health and the Faculty of Medicine and Dentistry. She leads the Centre for Evaluation and Methods and directs the Barts Clinical Trials Unit. Her expertise spans medical statistics, clinical trials, and epidemiology, with a focus on cancer screening, prevention, and addressing health inequalities.

Education: BSc in Mathematics (University of Liverpool), MSc in Epidemiology (University of Cambridge), PhD in Biostatistics (Queen Mary University of London).

Research interests include cancer detection and treatment, infectious diseases, and public health interventions. She has led trials in prostate cancer imaging, lung cancer screening, and smoking cessation for tuberculosis patients. Her work emphasizes methodological rigor and reducing health disparities.

Notable roles include leading the Yorkshire Lung Screening Trial and contributing to international studies on HIV prevention and venous leg ulcers. Her supervision spans projects on lung nodule risk assessment, breast screening strategies, and colorectal cancer modeling.

She collaborates with institutions worldwide and holds grants from Barts Charity, NIHR, and the Wolfson Institute.